Burden of community-acquired pneumonia in North American adults (Q37702741)

22 August 2017

1 reference

title

Burden of community-acquired pneumonia in North American adults (English)

1 reference

22 August 2017

0 references

1

Thomas M File

1 reference

22 August 2017

Thomas J Marrie

2

1 reference

PubMed ID

20203464

22 August 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

22 August 2017

Postgraduate Medicine

1 reference

22 August 2017

122

1 reference

22 August 2017

130-141

1 reference

22 August 2017

2

1 reference

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

22 August 2017

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Infectious disease hospitalizations in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Racial variations in processes of care for patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Indicators of recurrent hospitalization for pneumonia in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

The burden of community-acquired pneumonia in seniors: results of a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Association between initial empirical therapy and decreased length of stay among veteran patients hospitalized with community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Limited impact of a multicenter intervention to improve the quality and efficiency of pneumonia care

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Effectiveness of ceftriaxone plus doxycycline in the treatment of patients hospitalized with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Antibiotic Prescription for Community-Acquired Pneumonia in the Intensive Care Unit: Impact of Adherence to Infectious Diseases Society of America Guidelines on Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Low-risk patients admitted with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Antibiotic Therapy for Ambulatory Patients With Community-Acquired Pneumonia in an Emergency Department Setting

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Determinants for hospitalization in " low-risk" community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Community-acquired pneumonia in North American emergency departments: drug resistance and treatment success with clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Rehospitalizations among patients in the Medicare fee-for-service program

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Blood cultures do not change management in hospitalized patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Patients admitted to hospital with suspected pneumonia and normal chest radiographs: epidemiology, microbiology, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Paradise -- not without its plagues: overwhelming Blastomycosis pneumonia after visit to lakeside cottages in Northeastern Ontario

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Resource utilization of adults admitted to a large urban hospital with community-acquired pneumonia caused by Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Hospital-reported pneumococcal susceptibility to penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Increasing hospital admissions for pneumonia, England

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Epidemiology of community-acquired pneumonia in adults: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

The burden and treatment of diabetes in elderly individuals in the u.s.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Type 2 Diabetes and Pneumonia Outcomes: A population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Economic costs of diabetes in the U.S. In 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Costs of occupational COPD and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Improved clinical outcomes with utilization of a community-acquired pneumonia guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Treatment failure in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Physician awareness and self-reported use of local and national guidelines for community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Updating the Accounts: Global Mortality of the 1918-1920 "Spanish" Influenza Pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Deaths from bacterial pneumonia during 1918-19 influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Efficacy of pneumococcal vaccination in adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Predictors of pneumococcal polysaccharide vaccination among patients at three inner-city neighborhood health centers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2130

21 January 2018

Identifiers

DOI

10.3810/PGM.2010.03.2130

1 reference

release_jixurzkyfvebzlwmhho5ck5xvy

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jixurzkyfvebzlwmhho5ck5xvy

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

20203464

1 reference

PubMed ID

20203464